retatrutide glp-1 gip glucagon 10mg/vial Retatrutide is a next-generation triple-pathway

This is important for people on a high protein diet

From a pharmacokinetic perspective, besides increased gastric emptying, obesity has been suggested to modulate CYP gene expression, and increased fat mass may result in an increased Vd of lipophilic drugs

Scientists analyzed electronic medical records for more than 73,000 people and found that after 5 years, GLP-1 use was linked to a significantly higher risk of developing osteoporosis, compared to those not taking the medication

Therefore, the complementary mechanisms of action of an SGLT2 inhibitor and a GLP1-RA (through its effect to reduce appetite and possibly also its ability to slow gastric emptying) may provide an attractive approach for obesity treatment (Fig